XX Congresso Nazionale Società Italiana di ... - Salute per tutti
XX Congresso Nazionale Società Italiana di ... - Salute per tutti
XX Congresso Nazionale Società Italiana di ... - Salute per tutti
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>XX</strong> <strong>Congresso</strong> <strong>Nazionale</strong> <strong>Società</strong> <strong>Italiana</strong> <strong>di</strong> Urologia Oncologica<br />
Giovedì 24 Giugno 2010<br />
Giovedì 24 Giugno 2010 ore 08.30-09.30<br />
Aula necchi: Comunicazioni orali selezionate<br />
13 - SeX STeRoiDS MeTABoLiSM in BeniGn AnD MALiGnAnT PRoSTATe TiSSUe: An eX-vivo MoDeL To<br />
CHARACTeRiZe THe RoLe oF enZYMATiC PRoFiLe in BioLoGiCAL BeHAvioUR<br />
Isidori A.M. 1 , Franco G. 2 , Michetti M. 2 , Tartaglia N. 2 , Gianfrilli D. 1 , Ciccariello M. 3 , Lenzi A. 1<br />
1 Department of Me<strong>di</strong>cal Pathophysiology, Sapienza University of Rome, Italy; 2 Department of Urology, Sapienza University<br />
of Rome, Italy; 3 Department of Ra<strong>di</strong>ology, Sapienza University of Rome, Italy<br />
73 - PRoGnoSTiC vALUe oF KARYoTYPe AnALYSiS in CLeAR CeLL RenAL CARCinoMA:<br />
STUDY on 131 PATienTS WiTH LonG TeRM FoLLoW-UP<br />
Alessandro Antonelli, Nicola Arrighi, Regina Tardanico 1 , P. Balzarini 1 , Tiziano Zanotelli, Laura Perucchini, Alberto Cozzoli,<br />
Danilo Zani, Sergio Cosciani Cunico, Clau<strong>di</strong>o Simeone<br />
Chair and Division of Urology and 1 Chair and Department of Pathology, Spedali Civili Hospital, University of Brescia, Brescia, Italy<br />
106 - iS inTRAoPeRATive RADiATion THeRAPY AnD RADiCAL PRoSTATeCToMY BeTTeR<br />
THAn ADJUvAnT RADiATion THeRAPY AFTeR RADiCAL PRoSTATeCToMY<br />
FoR CLiniCAL LoCALLY ADvAnCeD PRoSTATe CAnCeR<br />
Giansilvio Marchioro 1 , Marco Krengli 2 , Matteo Vidali 3 , Alessandro Volpe 1 , Roberto Tarabuzzi 1 , Michele Billia 1 , Stefano Zaramella 1 ,<br />
Andrea Ballarè 2 , Pina Apicella 2 , Simone Crivellaro 4 , Bruno Frea 4 , Carlo Terrone 1<br />
1 Urology Department, Maggiore della Carità Hospital, University of Eastern Piedmont, Novara, Italy; 2 Department of Ra<strong>di</strong>otherapy<br />
Me<strong>di</strong>cine, Maggiore della Carità Hospital, University of Eastern Piedmont, Novara, Italy; 3 Clinical Chemistry Unit, University of<br />
Eastern Piedmont, Novara, Italy; 4 Urology Department, Santa Maria della Misericor<strong>di</strong>a Hospital, University of U<strong>di</strong>ne, U<strong>di</strong>ne<br />
150 - SUBGRoUP AnALYSiS AnD UPDATeD ReSULTS oF THe RAnDoMiZeD STUDY CoMPARinG SoRAFeniB PLUS<br />
inTeRLeUKin-2 veRSUS SoRAFeniB ALone AS FiRST Line TReATMenT in MeTASTATiC RenAL CeLL CARCinoMA<br />
Giuseppe Procopio 1 , Elena Verzoni 1 , Sergio Bracarda 2 , Giario Conti 3 , Valentina Guadalupi 1 , Cinzia Ortega 4 ,<br />
Nicola Nicolai 1 , Tullio Torelli 1 , Emilio Bajetta 1 , Roberto Salvioni 1<br />
1 On behalf of ITMO Study Group Fondazione IRCCS INT Milano, 2 A.O. Perugia, 3 Ospedale S. Anna Como, 4 IRCC Can<strong>di</strong>olo<br />
264 - SoLUBLe e-CADHeRin SeRUM LeveL vARiATionS in PATienTS WiTH PRoSTATe CAnCeR<br />
AFTeR RADiCAL ReTRoPUBiC PRoSTATeCToMY<br />
Fortunata Iacopino 1 , Francesco Pinto 2 , Alessandro Bertaccini 3 , Alessandro Calarco 2 , Gabriella Proietti 1 ,<br />
Angelo Totaro 2 , Giuseppe Martorana 3 , Pier Francesco Bassi 2 , Gigliola Sica 1<br />
1 Institute of Histology and Embryology; 2 Urology, Faculty of Me<strong>di</strong>cine, Catholic University of the Sacred Heart, Rome;<br />
3 Department of Urology, Alma Mater Stu<strong>di</strong>orum, University of Bologna, Italy<br />
277 - PRoSTATe-SPeCiFiC MeMBRAne AnTiGen (PSMA) eXPReSSion AnD PRoSTATe CAnCeR SURvivAL<br />
Julie Kas<strong>per</strong>zyk 1,2 , Stephen Finn 3 , Whitney Hendrickson 1 , Richard Flavin 3 , Michelangelo Fiorentino 3,4 ,<br />
Edward Giovannucci 1,2 , Meir Stampfer 1,2 , Massimo Loda 3,5 , Lorelei Mucci 1,2<br />
1 Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA; 2 Channing Laboratory, Brigham and Women’s<br />
Hospital and Harvard Me<strong>di</strong>cal School, Boston, MA, USA; 3 Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA;<br />
4 Pathology Unit, Addari Institute of Oncology, Sant'Orsola-Malpighi Hospital, Bologna, Italy; 5 Department of Pathology, Brigham<br />
and Women’s Hospital and Harvard Me<strong>di</strong>cal School, Boston, MA<br />
Giovedì 24 Giugno 2010 ore 08.30-09.30<br />
Aula Moscati: Comunicazioni orali selezionate<br />
11 - PT2-3n0M0 PRoSTATe CAnCeR WiTH PoSiTive AnD neGATive MARGinS: CLiniCAL oUTCoMe<br />
AnD TiMe To SALvAGe RADioTHeRAPY<br />
Michele Lodde, Louis Lacombe, Yves Fradet<br />
Department of Urology, Université Laval, CHUQ-Hotel-Dieu de Québec, Québec, QC<br />
195 - inTeGRATeD MULTiDiSCiPLinARY APPRoACH To MeTASTATiC RenAL CARCinoMA in An eXPeRiMenTALLY<br />
PRoJeCT oF URo-onCoLoGY CooPeRATion<br />
Daniele Masala 1 , Pompeo Brigante 1 , Maurizio Carrino 1 , Domenico Di Lorenzo 1 , Domenico Taglialatela 1 ,<br />
Alberto Masala 1 , Giacomo Cartenì 2<br />
1 Dipartimento Nefro-Urologico e U.O.C. Urologia Ospedale A. Cardarelli, Napoli; 2 UOC Oncologia Ospedale A. Cardarelli, Napoli<br />
196 - iMPRoveD DeTeCTion oF LoW GRADe PRoSTATe CAnCeR BY PSA-iGM ASSeSSMenT<br />
Michela Verna 1 , Paolo Pengo 1 , Andrea Gallotta 1 , Danilo Zani 2 , Silvia Costa 2 , Antonette E. Leon 3 ,<br />
Massimo Gion 3 , Giorgio Fassina 1 , Luca Beneduce 1<br />
1 XEPTAGEN SpA, Marghera Venice, Italy; 2 Department of Urology, University of Brescia, Italy; 3 ABO Association, Regional Center for<br />
the Study of Biological Markers of Malignancy, AULSS 12, Venezia<br />
216 - CReATion oF A PRoSTATe CAnCeR TiSSUe BAnK: neW TeCHniQUe<br />
Luca Carmignani, Stefano Picozzi, Robert Stubinski, Stefano Casellato, Giorgio Bozzini, Luca Lunelli, Domenico Arena<br />
Urology Department, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy<br />
24<br />
Archivio Italiano <strong>di</strong> Urologia e Andrologia 2010; 82, 2, Supplemento 1